PGT-A in IVF: What It Can Tell You, What It Can’t, and Why It’s Not Automatic

PGT-A is sometimes presented like IVF’s premium upgrade:

“Test the embryos first, transfer the good ones, improve your odds.”

Real life is messier.

Quick answer: PGT-A analyzes cells biopsied from a blastocyst for chromosome copy-number findings. It can help with embryo selection in some situations, but current professional guidance does not support treating it as a proven universal benefit for every IVF patient.

Medical note: PGT decisions are especially personal because age, embryo number, prior losses, genetic history, cost, and clinic policy can all matter.

What does PGT-A stand for?

Preimplantation genetic testing for aneuploidy.

A small number of cells are usually biopsied from the trophectoderm of a blastocyst.

The embryo is typically frozen while the sample is analyzed.

Results may be reported as:

• euploid
• aneuploid
• mosaic
• inconclusive / no result

Exact reporting systems vary by laboratory.

What is PGT-A actually looking for?

In simplified terms, it looks for evidence that the sampled cells have the expected chromosome copy numbers or show aneuploidy.

That can give the clinic another piece of information when deciding which embryo to transfer.

What PGT-A does not tell you

It does not:

• test for every genetic disease
• prove an embryo is genetically “perfect”
• guarantee implantation
• guarantee live birth
• eliminate miscarriage risk
• predict every future health outcome

It is also different from PGT-M, which can be used when there is risk for a specific single-gene condition.

So does PGT-A improve IVF success?

This is where marketing gets ahead of the evidence.

ASRM’s 2024 committee opinion states that the value of routine PGT-A screening for all IVF patients has not been demonstrated.

That does not mean PGT-A is useless.

It means the better question is:

What decision would this test change for me?

Why does age come up so often?

Aneuploidy becomes more common with increasing maternal age.

So PGT-A discussions are often more relevant in older IVF populations.

But age is not the only variable.

Imagine two patients who are the same age:

• Patient A has 1 blastocyst.
• Patient B has 9 blastocysts.

Those are very different embryo-selection problems.

The possible value of PGT-A can look different too.

What is a mosaic result?

A mosaic result suggests the biopsied sample contains a mixture of findings rather than a uniform euploid or aneuploid result.

This is one reason PGT-A is not a perfect sorting machine.

The biopsy samples a small number of trophectoderm cells. It does not inspect every cell in the embryo.

Mosaic results can create complicated transfer decisions and are a good reason to ask what your clinic and testing lab actually do with those findings.

The cost question matters too

The quoted PGT-A fee may not be the full bill.

Depending on the clinic, costs can include:

• embryo biopsy
• genetic laboratory testing
• embryo freezing
• storage
• a later frozen embryo transfer

So even if the test itself looks affordable, compare the entire path.

Questions to ask before saying yes

1. What problem are we trying to solve with this test?
2. Would the result change which embryo you transfer?
3. How many blastocysts do you realistically expect me to have?
4. How do you report mosaic embryos?
5. Will you transfer selected mosaic embryos?
6. What happens after an inconclusive result?
7. What is the total cost including biopsy, testing, freezing, storage, and FET?
8. Would we still do a frozen transfer if we skipped PGT-A?

If nobody can explain what decision the test is supposed to change, keep asking.

💡 What this means

Do not ask only:

“Is PGT-A good?”

Ask:

“What information will it give us, and what will we do differently because of that information?”

That is a much better fertility-treatment question.

Next: How to compare IVF clinics without getting played by the success-rate number

FAQ

Is PGT-A the same as embryo grading?
No. Grading describes morphology. PGT-A analyzes chromosome copy-number findings in biopsied cells.

Does a euploid result guarantee a baby?
No.

Is PGT-A recommended for every IVF patient?
No. Routine use for all IVF patients has not been shown to improve outcomes across the board.

Sources

• ASRM, The Use of PGT-A: Committee Opinion 2024: https://www.asrm.org/practice-guidance/practice-committee-documents/the-use-of-preimplantation-genetic-testing-for-aneuploidy-a-committee-opinion-2024/